Active ingredients: leflunomide
What it is used for
ARAVA is indicated for the treatment of: Active rheumatoid arthritis. Active Psoriatic Arthritis. ARAVA is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. The combined use of ARAVA with other Disease Modifying Anti-Rheumatic Drugs (DMARDS) has not been adequately studied (see PRECAUTIONS).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
White to almost white, round film-coated tablets with the embossing ZBN.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website
Pregnant or planning a pregnancy?
For the active ingredient leflunomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)